<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Vaccines (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Vaccines (Basel)</journal-id><journal-id journal-id-type="publisher-id">vaccines</journal-id><journal-title-group><journal-title>Vaccines</journal-title></journal-title-group><issn pub-type="epub">2076-393X</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11680215</article-id><article-id pub-id-type="doi">10.3390/vaccines12121352</article-id><article-id pub-id-type="publisher-id">vaccines-12-01352</article-id><article-categories><subj-group subj-group-type="heading"><subject>Systematic Review</subject></subj-group></article-categories><title-group><article-title>Determinants of COVID-19 Vaccine Acceptance and Hesitancy: A Systematic Review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>De Ara&#x000fa;jo</surname><given-names>Juliana Soares Ten&#x000f3;rio</given-names></name><xref rid="af1-vaccines-12-01352" ref-type="aff">1</xref><xref rid="c1-vaccines-12-01352" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3562-3246</contrib-id><name><surname>Delpino</surname><given-names>Felipe Mendes</given-names></name><xref rid="af2-vaccines-12-01352" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5843-1733</contrib-id><name><surname>Andrade-Gon&#x000e7;alves</surname><given-names>Rubia Laine de Paula</given-names></name><xref rid="af1-vaccines-12-01352" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Arag&#x000e3;o</surname><given-names>Francisca Bruna Arruda</given-names></name><xref rid="af1-vaccines-12-01352" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1463-8155</contrib-id><name><surname>Ferezin</surname><given-names>Let&#x000ed;cia Perticarrara</given-names></name><xref rid="af3-vaccines-12-01352" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Santos</surname><given-names>Denise Alves</given-names></name><xref rid="af1-vaccines-12-01352" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Neto</surname><given-names>Neemais Costa Duarte</given-names></name><xref rid="af4-vaccines-12-01352" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3436-2654</contrib-id><name><surname>do Nascimento</surname><given-names>Murilo C&#x000e9;sar</given-names></name><xref rid="af5-vaccines-12-01352" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Moreira</surname><given-names>Sim&#x000e3;o Pedro Tavares</given-names></name><xref rid="af6-vaccines-12-01352" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name><surname>Ribeiro</surname><given-names>Gabriela Ferreira</given-names></name><xref rid="af6-vaccines-12-01352" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name><surname>Alves</surname><given-names>Rayssa Francielly dos Santos</given-names></name><xref rid="af6-vaccines-12-01352" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4792-8714</contrib-id><name><surname>Arc&#x000ea;ncio</surname><given-names>Ricardo Alexandre</given-names></name><xref rid="af3-vaccines-12-01352" ref-type="aff">3</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>La Torre</surname><given-names>Giuseppe</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-vaccines-12-01352"><label>1</label>Campus S&#x000e3;o Paulo, University of S&#x000e3;o Paulo, S&#x000e3;o Paulo 05508-220, SP, Brazil; <email>rubia@eerp.usp.br</email> (R.L.d.P.A.-G.); <email>aragao_bruna@usp.br</email> (F.B.A.A.); <email>niisealvessantos1@gmail.com</email> (D.A.S.)</aff><aff id="af2-vaccines-12-01352"><label>2</label>Campus Pelotas, Federal University of Pelotas, Pelotas 96010-610, RS, Brazil; <email>fmdsocial@outlook.com</email></aff><aff id="af3-vaccines-12-01352"><label>3</label>Ribeir&#x000e3;o Preto College of Nursing, Campus Ribeir&#x000e3;o Preto, University of Sao Paulo, Ribeir&#x000e3;o Preto 14040-902, SP, Brazil; <email>lehferezin@usp.br</email> (L.P.F.); <email>ricardo@eerp.usp.br</email> (R.A.A.)</aff><aff id="af4-vaccines-12-01352"><label>4</label>Campus S&#x000e3;o Lu&#x000ed;s, Federal University of Maranh&#x000e3;o, S&#x000e3;o Lu&#x000ed;s 65020-070, MA, Brazil; <email>neemiascosta50@gmail.com</email></aff><aff id="af5-vaccines-12-01352"><label>5</label>Nursing School, Campus Sede, Federal University of Alfenas, Alfenas 37130-001, MG, Brazil; <email>murilo.nascimento@unifal-mg.edu.br</email></aff><aff id="af6-vaccines-12-01352"><label>6</label>Campus Macei&#x000f3;, State University of Health Sciences of Alagoas, Macei&#x000f3; 57010-300, AL, Brazil; <email>simaoptm@gmail.com</email> (S.P.T.M.); <email>gabriela.ribeiro@academico.uncisal.edu.br</email> (G.F.R.); <email>rayssa.alves@academico.uncisal.edu.br</email> (R.F.d.S.A.)</aff><author-notes><corresp id="c1-vaccines-12-01352"><label>*</label>Correspondence: <email>julianatenorio17@usp.br</email></corresp></author-notes><pub-date pub-type="epub"><day>29</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2024</year></pub-date><volume>12</volume><issue>12</issue><elocation-id>1352</elocation-id><history><date date-type="received"><day>31</day><month>10</month><year>2024</year></date><date date-type="rev-recd"><day>22</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>26</day><month>11</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2024 by the authors.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><bold>Background/Objectives:</bold> COVID-19 is an infectious disease whose prevention is significantly aided by vaccination, which reduces both case severity and mortality. Despite the safety and efficacy of vaccines, acceptance is not universal, and understanding of the factors influencing vaccination decisions and hesitancy remains limited. This review aims to identify and analyze studies addressing two key questions: what influences the decision to vaccinate and what factors are associated with vaccine hesitancy. <bold>Methods:</bold> This systematic review was conducted following the PRISMA guidelines. Data collection utilized descriptors related to vaccine adherence and hesitancy, based on the PEO strategy of the Joanna Briggs Institute (JBI). Searches were conducted in Embase, Scopus, PubMed, Lilacs, and Web of Science, focusing on publications from 2021, the year the first COVID-19 vaccine was approved. After excluding duplicates and selecting articles based on eligibility criteria, the analysis involved data extraction and methodological quality assessment using JBI tools. <bold>Results:</bold> A total of 5268 publications were identified, with 30 included in this study. Factors associated with vaccine hesitancy included low education levels, social media influence, confidence in vaccine safety, and fear of side effects. In contrast, factors linked to vaccine acceptance included higher education, higher income, older age, and existing comorbidities. <bold>Conclusions:</bold> The findings highlight the urgent need for targeted health communication and education strategies, particularly for vulnerable groups. Public health policies should incorporate these factors to enhance vaccination adherence and build public confidence in vaccine safety, which is essential for mitigating future health emergencies.</p></abstract><kwd-group><kwd>vaccination</kwd><kwd>vaccine acceptance</kwd><kwd>vaccine hesitancy</kwd><kwd>COVID-19</kwd></kwd-group><funding-group><award-group><funding-source>Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior&#x02014;Brasil (CAPES)</funding-source><award-id>88887.657730/2021-00</award-id></award-group><award-group><funding-source>Programa Impactos CAPES and by S&#x000e3;o Paulo State Research Support Foundation</funding-source><award-id>2021/08263-7</award-id></award-group><award-group><funding-source>Post-doctoral fellowship</funding-source><award-id>2022/03964-0</award-id></award-group><award-group><funding-source>Research Productivity Scholarship</funding-source><award-id>307014/2022-3</award-id></award-group><funding-statement>This study was sponsored by the Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior&#x02014;Brasil (CAPES)&#x02014;Finance Code 001 Process: 88887.657730/2021-00&#x02014;Programa Impactos CAPES and by S&#x000e3;o Paulo State Research Support Foundation (FAPESP) grant number 2021/08263-7. Post-doctoral fellowship (FAPESP process&#x02014;2022/03964-0); CNPQ (Research Productivity Scholarship&#x02014;Process Processo: 307014/2022-3).</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-vaccines-12-01352"><title>1. Introduction</title><p>COVID-19 is an infectious disease that can be prevented through vaccination. The vaccine not only protects against infection but also reduces the severity of cases, thereby decreasing the associated morbidity and mortality rates [<xref rid="B1-vaccines-12-01352" ref-type="bibr">1</xref>,<xref rid="B2-vaccines-12-01352" ref-type="bibr">2</xref>]. Since the onset of the COVID-19 pandemic, over 6 million people have lost their lives due to the infection, highlighting the seriousness of the global challenge we still face [<xref rid="B2-vaccines-12-01352" ref-type="bibr">2</xref>].</p><p>Despite advances in vaccination, the global immunization rate remains below the target set by the World Health Organization, which aimed to achieve 65.09% of the world population fully vaccinated by 12 August 2024 [<xref rid="B3-vaccines-12-01352" ref-type="bibr">3</xref>]. This situation poses a significant obstacle to controlling the pandemic and highlights the need for ongoing efforts in awareness campaigns and access to vaccines.</p><p>It is well known that vaccination is an effective and safe tool in the fight against COVID-19, and its progress has significantly reduced the occurrence of severe cases and deaths [<xref rid="B1-vaccines-12-01352" ref-type="bibr">1</xref>,<xref rid="B2-vaccines-12-01352" ref-type="bibr">2</xref>]. Thus, vaccines are a key element in the package of measures aimed at controlling the spread of the new coronavirus. In this context, despite being a health investment with excellent cost-effectiveness, resulting in a tremendous impact on health by preventing millions of deaths each year, vaccine acceptance is not universal [<xref rid="B4-vaccines-12-01352" ref-type="bibr">4</xref>].</p><p>There are gaps in knowledge regarding the factors associated with individuals&#x02019; decisions to get vaccinated against COVID-19, as well as the behavioral patterns related to vaccine hesitancy during the pandemic. This evidence is crucial for health institutions and organizations to prepare for and effectively address future public health emergencies. Through a review, it becomes possible to assess the state of the art concerning the factors that influence an individual&#x02019;s decision to vaccinate. This information can be valuable for health managers in developing awareness campaigns about the importance of vaccination.</p><p>The aim of this review is to identify and analyze studies addressing two key questions: what influences the decision to vaccinate and what factors are associated with vaccine hesitancy.</p></sec><sec id="sec2-vaccines-12-01352"><title>2. Materials and Methods</title><sec id="sec2dot1-vaccines-12-01352"><title>2.1. Type of Study</title><p>This is a systematic review conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [<xref rid="B5-vaccines-12-01352" ref-type="bibr">5</xref>] guidelines and registered with PROSPERO (International prospective register of systematic reviews; Centre for Reviews and Dissemination, University of York, York, UK; <uri xlink:href="https://www.crd.york.ac.uk/prospero/">https://www.crd.york.ac.uk/prospero/</uri> (accessed on 8 April 2024)) CRD42024534308. The guiding questions were: &#x0201c;What factors are associated with the decision to get vaccinated?&#x0201d; and &#x0201c;What factors are associated with vaccine hesitancy?&#x0201d; We used the PEO (Population, exposure and outcome) strategy proposed by the Joanna Briggs Institute 6 for systematic reviews, which recognizes this approach as the most suitable for formulating questions about the effects of exposure.</p></sec><sec id="sec2dot2-vaccines-12-01352"><title>2.2. Search Strategy</title><p>The searches were conducted in April 2024, without language restrictions. We searched for studies published from 2021 to 2024, as that was the year the first COVID-19 vaccine was approved for use. The searches were carried out in the following databases: Excerpta Medica database (Embase<sup>&#x000ae;</sup>&#x02014;<uri xlink:href="https://www.embase.com">https://www.embase.com</uri>), Scopus, owned by Elsevier (<uri xlink:href="https://www.scopus.com">https://www.scopus.com</uri>), PubMed (<uri xlink:href="https://pubmed.ncbi.nlm.nih.gov/">https://pubmed.ncbi.nlm.nih.gov/</uri>), and the Latin American and Caribbean Health Sciences Literature (LILACS&#x02014;accessed through the Regional Portal of the Virtual Health Library&#x02014;<uri xlink:href="https://pesquisa.bvsalud.org/portal/advanced">https://pesquisa.bvsalud.org/portal/advanced</uri> (accessed on 8 April 2024)), as well as Web of Science. The searches were conducted using vocabulary in English.</p><p>We conducted the searches using specific strategies for each database, along with the boolean operators AND and OR. The boolean operator OR was used between words within the same group (&#x0201c;word&#x0201d; OR &#x0201c;word&#x0201d;), while AND was used between sets of words from different groups (&#x0201c;set of words from group<sub>1</sub>&#x0201d; AND &#x0201c;set of words from group<sub>2</sub>&#x0201d; AND &#x0201c;set of words from group<sub>3</sub>&#x0201d;).</p></sec><sec id="sec2dot3-vaccines-12-01352"><title>2.3. Inclusion Criteria</title><p>Only primary observational and analytical studies that addressed factors associated with vaccination adherence or hesitancy regarding COVID-19 within the general population were included. The selected articles needed to be published from 2021 onward, as COVID-19 vaccines began to be implemented that year.</p></sec><sec id="sec2dot4-vaccines-12-01352"><title>2.4. Exclusion Criteria</title><p>Studies that did not address the general population, such as research focused on specific population groups, were excluded from the review, along with articles that did not directly answer the outlined research questions. Additionally, comments, editorials, reviews, case reports, protocols, theses, dissertations, and conference abstracts that did not provide primary or analytical data were also excluded.</p></sec><sec id="sec2dot5-vaccines-12-01352"><title>2.5. Export of Studies</title><p>The search results were exported to Rayyan, a free online tool that uses artificial intelligence to facilitate study screening in systematic reviews. After removing duplicates, two independent reviewers screened the titles and abstracts of the remaining studies. Those that met the eligibility criteria were selected for full-text reading, where a new screening was conducted to identify the studies to be included in the review. This rigorous process ensured the inclusion of relevant and methodologically sound studies.</p></sec><sec id="sec2dot6-vaccines-12-01352"><title>2.6. Quality Assessment</title><p>The methodological quality of the articles was assessed using specific tools proposed by the Joanna Briggs Institute (JBI) [<xref rid="B6-vaccines-12-01352" ref-type="bibr">6</xref>]. In this case, tools for evaluating cross-sectional studies were used, allowing us to indicate the number of items adequately addressed in the studies based on the number of items outlined by the tools (eight items for cross-sectional studies). Limitations noted in the articles were also considered to complement this evaluation. No study was excluded based on the methodological quality assessment.</p></sec><sec id="sec2dot7-vaccines-12-01352"><title>2.7. Data Analysis</title><p>The included articles were subjected to a narrative synthesis after data extraction, performed by one reviewer and verified by another. For this, a specific instrument based on Ursi was used, which included the following variables: article title, authors, journal name, year of publication, study type, objective, sample size, main results, and methodological quality assessment. The results were presented in summary tables and complemented by the analysis in the discussion.</p></sec></sec><sec sec-type="results" id="sec3-vaccines-12-01352"><title>3. Results</title><sec id="sec3dot1-vaccines-12-01352"><title>3.1. Selection of Studies</title><p>The search identified 5259 scientific publications, of which 2788 were excluded for being duplicates and 2471 were retained after reading their titles and abstracts. As a result, 361 publications were deemed eligible for full-text reading, of which 331 were excluded for not meeting the inclusion criteria, leaving 30 articles in the review (<xref rid="vaccines-12-01352-f001" ref-type="fig">Figure 1</xref>).</p></sec><sec id="sec3dot2-vaccines-12-01352"><title>3.2. Characteristics of the Studies</title><p>The studies included in the review were conducted across different continents, including Africa, Asia, North America, and Europe, encompassing diverse populations (<xref rid="app1-vaccines-12-01352" ref-type="app">Supplementary Material Table S1</xref>). They were published between 2021 and 2023 and focused on the general population to investigate factors related to COVID-19 vaccination. The articles primarily used observational and analytical methodologies, with sample sizes ranging from hundreds to thousands of participants. Data sources included cross-sectional surveys and questionnaires administered in specific populations, both in urban and rural areas.</p><p>These studies analyzed sociodemographic, behavioral, and psychological factors, aiming to identify patterns of vaccine acceptance or hesitancy. Notable methods included structured questionnaires and in-person interviews, with data collected directly from populations or through online platforms. Most studies included variables such as age, education, income, exposure to information, and beliefs related to vaccine safety.</p><p>Some studies addressed large populations, such as one conducted in nine countries that included 9264 participants, while another study in Egypt had 24,376 participants. Smaller samples were also common, such as in the study conducted in Saudi Arabia with 531 participants. The majority of the studies included in this review, i.e., 22 studies, had more than 1000 participants. Overall, sample sizes varied from a few hundred to tens of thousands, depending on the country or region of interest. These samples were mainly collected through cross-sectional designs, allowing for the assessment of data at a single point in time.</p><p>The characteristics of participants showed significant diversity across the studies, reflecting the sociodemographic variability of the analyzed countries. Most studies had a high participation of women, such as the study conducted in nine countries, where the sample was predominantly females aged 55 years or older. In contrast, other studies, like the one in Ghana, presented a more balanced profile between men and women, with an average age of 40 years. Educational levels varied significantly among the studies, with some highlighting a high percentage of participants with higher education, while others, such as those in Ghana and Nigeria, included a significant proportion of individuals without formal education or with lower educational levels. Additionally, factors such as marital status, occupation, and religious beliefs influenced vaccine hesitancy in various regions, demonstrating the complexity of sociocultural predictors in vaccine acceptance.</p></sec><sec id="sec3dot3-vaccines-12-01352"><title>3.3. Main Results</title><p>The main findings from the studies included in the systematic review reveal a diverse landscape of factors associated with COVID-19 vaccine acceptance and hesitancy across different populations and regions of the world. As described in <xref rid="vaccines-12-01352-t001" ref-type="table">Table 1</xref> and <xref rid="vaccines-12-01352-t002" ref-type="table">Table 2</xref>, in many studies, vaccine acceptance was strongly linked to sociodemographic characteristics such as higher education levels, greater income, older age, and the presence of comorbidities. Individuals with higher educational attainment were more likely to accept vaccination, partly due to a better understanding of the vaccine&#x02019;s benefits and greater trust in available scientific information.</p><p>Conversely, vaccine hesitancy was often associated with fear of side effects, distrust regarding the efficacy and safety of vaccines, and reliance on information from unreliable sources, such as social media. In several countries, social media use was identified as a significant negative predictor for vaccine acceptance, particularly in regions where misinformation about vaccination effects was widely disseminated. Additionally, psychological factors, such as high levels of stress and distrust in government or health authorities, also contributed to hesitancy.</p><p>The studies highlighted that younger populations and those with lower education levels showed greater resistance to vaccination. Fear of long-term adverse effects, combined with the belief that the vaccine was developed too quickly, significantly contributed to this hesitancy, especially in contexts where information about the vaccine development process was not adequately disseminated. In some regions, religion and cultural beliefs also played an important role in the decision to get vaccinated or not.</p><p>Another relevant finding was the association between trust in health institutions and vaccine adherence. Studies conducted in contexts where vaccination campaigns were widely supported by trusted authorities, such as doctors and community leaders, demonstrated higher vaccine acceptance. In contrast, in countries or regions where the population had less confidence in government authorities or the healthcare system, vaccine hesitancy was more prevalent.</p></sec><sec id="sec3dot4-vaccines-12-01352"><title>3.4. Quality of the Studies</title><p>The assessment of the methodological quality of the studies included in the review was conducted using specific tools proposed by the Joanna Briggs Institute (JBI), applicable to cross-sectional studies. Each study was evaluated based on eight criteria related to methodology, such as sample adequacy, clarity of objectives, and rigor in data analysis. Scores ranged from 5 to 8 points, with 8 being the maximum possible score. The average score across the studies was 6.4, indicating that most met the methodological criteria satisfactorily, despite some identified limitations.</p><p>The studies with lower scores exhibited limitations primarily related to sample size and representativeness, as well as potential selection biases. In contrast, the studies with higher scores demonstrated consistent methodological rigor, featuring representative samples and robust analyses that clearly addressed the factors associated with vaccine acceptance and hesitancy. No studies were excluded based on methodological quality; however, the identified limitations were taken into account in the interpretation of the results.</p></sec></sec><sec sec-type="discussion" id="sec4-vaccines-12-01352"><title>4. Discussion</title><p>The objective of this systematic review was to evaluate the factors associated with COVID-19 vaccine acceptance and hesitancy. The analysis of the 30 included studies revealed a multifactorial landscape influencing the population&#x02019;s decision to engage in vaccination. Key findings highlighted sociodemographic factors, such as education level, income, age, and the presence of comorbidities, which were related to higher vaccine acceptance. Conversely, fear of adverse effects, distrust in vaccine safety, and exposure to misinformation&#x02014;particularly through social media&#x02014;were the factors most associated with vaccine hesitancy.</p><p>The interpretation of these findings suggests that vaccine acceptance is closely tied to access to information and the level of trust in health authorities. Individuals with higher education and income tend to have a clearer understanding of vaccine safety and efficacy, which promotes greater adherence. In contrast, vaccine hesitancy is heavily influenced by the spread of misinformation and fear of side effects&#x02014;issues that need to be addressed through appropriate communication campaigns. Moreover, trust in government and health institutions plays a crucial role: contexts with high levels of trust show greater vaccine uptake, while distrust exacerbates hesitancy. Given this landscape of various factors that can influence vaccine acceptance, it is essential for health authorities to encourage the adoption of differentiated approaches in their strategies, fostering ongoing dialogue with all segments of the population [<xref rid="B37-vaccines-12-01352" ref-type="bibr">37</xref>].</p><p>A central aspect contributing to vaccine hesitancy, identified in several studies included in this review, is the fear of side effects and distrust regarding the safety of COVID-19 vaccines. This fear is often fueled by the spread of misinformation, particularly through social media, where rumors and conspiracy theories circulate. In some contexts, this misinformation has been exacerbated by a lack of effective health education campaigns that directly address these fears.</p><p>Combating vaccine hesitancy, therefore, requires a coordinated public communication strategy aimed at restoring trust in vaccines by disseminating clear and accessible scientific information, as well as using reliable sources for sharing this information. In Brazil, during the pandemic, this scenario was evident and was linked to information propagated by the government at the time, which contributed to some of the refusals related to vaccination.</p><p>This review reveals that sociodemographic factors, such as education level, income, and age, directly influence decisions regarding vaccine acceptance. Individuals with higher levels of education, for instance, tend to be more receptive to vaccination due to a better understanding of the vaccine&#x02019;s benefits. Conversely, those with lower education levels or limited access to quality information are more likely to exhibit vaccine hesitancy. Inequality in access to information and healthcare services also emerges as a critical issue, especially in less developed or rural areas. To overcome these barriers, it is essential for vaccination campaigns to be directed inclusively, using language and methods that reach these vulnerable groups, ensuring that information is conveyed clearly and understandably.</p><p>The results also suggest that trust in health institutions and the healthcare system of each country plays a crucial role in vaccine adherence. In countries where vaccination campaigns were widely supported by community leaders, doctors, and other trusted figures, there was a higher uptake of vaccines. Conversely, in contexts where there is a history of distrust in health authorities&#x02014;whether due to political reasons or previous management of health crises&#x02014;vaccine hesitancy was more pronounced. Creating regional campaigns that involve local and community leaders can be an effective strategy to overcome this barrier, ensuring that the message about the importance of vaccination is disseminated in a more trustworthy and accessible manner for the entire population.</p><p>The COVID-19 vaccine is one of the key tools for controlling the pandemic, but its success also depends on combating misinformation. The spread of fake news during the pandemic may have contributed to some of these findings. Efforts to counter fake news during the pandemic have helped to improve misinformation to some extent, but this is an action that needs to be ongoing [<xref rid="B38-vaccines-12-01352" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01352" ref-type="bibr">39</xref>]. Groups with lower education levels and limited access to reliable information are especially vulnerable to incorrect information. Therefore, evidence-based educational campaigns focused on debunking myths and promoting trust in health authorities are essential. Clear and accessible communication, combined with the dissemination of accurate information, is vital for overcoming vaccine hesitancy and preparing society to face future health crises.</p><p>In terms of limitations, some of the included studies presented methodological issues, such as small or poorly representative samples of certain populations, which may have affected the generalizability of the results. Selection biases were also identified in some studies, potentially limiting the accuracy of the conclusions. Additionally, due to the heterogeneity of the studies, it was not possible to conduct a meta-analysis to evaluate the results in an aggregated manner. It is recommended that longitudinal studies be conducted to better understand the risk factors for vaccine adherence or hesitancy, which could contribute to making future vaccination campaigns as successful as possible.</p><p>Among the strengths of this review is the geographic diversity of the included studies, spanning different continents and populations, as well as the number of studies incorporated. This diversity provides a comprehensive view of the factors influencing vaccine hesitancy and acceptance in various cultural and social contexts. Additionally, the rigor in the selection and evaluation of studies, following the PRISMA guidelines, ensures that all relevant studies are included and that the best available information in the literature is obtained.</p><p>Future perspectives include the need for more longitudinal studies that explore the evolution of factors associated with vaccination over time, particularly in future vaccination campaigns against other diseases. Additionally, evidence-based communication strategies should be prioritized to combat misinformation and increase confidence in vaccination. Awareness campaigns targeted at groups more vulnerable to hesitancy, such as young people and those with lower education levels, can be crucial for increasing vaccination rates and effectively combating future pandemics.</p></sec><sec sec-type="conclusions" id="sec5-vaccines-12-01352"><title>5. Conclusions</title><p>This systematic review highlighted the key factors associated with vaccine acceptance and hesitancy regarding COVID-19 in different population contexts. Sociodemographic factors, such as higher education, elevated income, and older age, were significant predictors of vaccine acceptance, while fear of side effects, distrust in vaccine safety, and exposure to misinformation were the main factors related to hesitancy. Trust in health institutions also played an essential role, with greater vaccine acceptance in contexts where this trust was higher. These findings are crucial for guiding public policies and awareness campaigns aimed at increasing vaccine adherence.</p><p>In light of the challenges posed by vaccine hesitancy, it is essential to invest in more effective communication strategies that clarify doubts and mitigate the impact of misinformation. Additionally, understanding the sociocultural barriers that influence vaccine acceptance can aid in developing targeted interventions for more vulnerable groups. Recognizing these factors is crucial not only for combating the COVID-19 pandemic but also for equipping health authorities to address future public health emergencies more efficiently.</p></sec></body><back><ack><title>Acknowledgments</title><p>This study was financed in part by the Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior&#x02014;Brasil (CAPES)&#x02014;Finance Code 001.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-vaccines-12-01352"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/vaccines12121352/s1">https://www.mdpi.com/article/10.3390/vaccines12121352/s1</uri>, Table S1. Description of articles included in the systematic review on factors associated with vaccine adherence or hesitancy against COVID-19, Ribeir&#x000e3;o Preto, 2024; Table S2. Preparation of the study question according to the PEO strategy, Ribeir&#x000e3;o Preto, 2024; Table S3. Bibliographic search strategy used in the systematic review on the factors associated with vaccine adherence or hesitancy against COVID-19, according to the databases researched, Ribeir&#x000e3;o Preto, 2024</p><supplementary-material id="vaccines-12-01352-s001" position="float" content-type="local-data"><media xlink:href="vaccines-12-01352-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, J.S.T.D.A. and F.M.D.; methodology, R.L.d.P.A.-G., F.B.A.A., D.A.S. and N.C.D.N.; software, S.P.T.M.; validation, J.S.T.D.A., L.P.F. and R.A.A.; formal analysis, M.C.d.N., J.S.T.D.A. and F.B.A.A.; investigation, J.S.T.D.A., F.B.A.A., S.P.T.M., G.F.R. and R.F.d.S.A.; resources, R.A.A.; data curation, J.S.T.D.A.; writing&#x02014;original draft preparation, J.S.T.D.A. and F.M.D.; writing&#x02014;review and editing, F.M.D., L.P.F. and R.A.A.; visualization, J.S.T.D.A.; supervision, J.S.T.D.A.; project administration, R.A.A.; funding acquisition, R.A.A. All authors have read and agreed to the published version of the manuscript.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-vaccines-12-01352"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gra&#x000f1;a</surname><given-names>C.</given-names></name>
<name><surname>Ghosn</surname><given-names>L.</given-names></name>
<name><surname>Evrenoglou</surname><given-names>T.</given-names></name>
<name><surname>Jarde</surname><given-names>A.</given-names></name>
<name><surname>Minozzi</surname><given-names>S.</given-names></name>
<name><surname>Bergman</surname><given-names>H.</given-names></name>
<name><surname>Buckley</surname><given-names>B.S.</given-names></name>
<name><surname>Probyn</surname><given-names>K.</given-names></name>
<name><surname>Villanueva</surname><given-names>G.</given-names></name>
<name><surname>Henschke</surname><given-names>N.</given-names></name>
<etal/>
</person-group><article-title>Efficacy and safety of COVID-19 vaccines</article-title><source>Cochrane Database Syst. Rev.</source><year>2022</year><volume>12</volume><fpage>CD015477</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD015477</pub-id><pub-id pub-id-type="pmid">36473651</pub-id>
</element-citation></ref><ref id="B2-vaccines-12-01352"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Beladiya</surname><given-names>J.</given-names></name>
<name><surname>Kumar</surname><given-names>A.</given-names></name>
<name><surname>Vasava</surname><given-names>Y.</given-names></name>
<name><surname>Parmar</surname><given-names>K.</given-names></name>
<name><surname>Patel</surname><given-names>D.</given-names></name>
<name><surname>Patel</surname><given-names>S.</given-names></name>
<name><surname>Dholakia</surname><given-names>S.</given-names></name>
<name><surname>Sheth</surname><given-names>D.</given-names></name>
<name><surname>Boddu</surname><given-names>S.H.S.</given-names></name>
<name><surname>Patel</surname><given-names>C.</given-names></name>
</person-group><article-title>Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Controlled and Randomized Clinical Trials</article-title><source>Rev. Med. Virol.</source><year>2024</year><volume>34</volume><fpage>e2507</fpage><pub-id pub-id-type="doi">10.1002/rmv.2507</pub-id><pub-id pub-id-type="pmid">38282394</pub-id>
</element-citation></ref><ref id="B3-vaccines-12-01352"><label>3.</label><element-citation publication-type="webpage"><person-group person-group-type="author">
<name><surname>Ritchie</surname><given-names>H.</given-names></name>
<name><surname>Ortiz-Ospina</surname><given-names>E.</given-names></name>
<name><surname>Beltekian</surname><given-names>D.</given-names></name>
<name><surname>Mathieu</surname><given-names>E.</given-names></name>
<name><surname>Hasell</surname><given-names>J.</given-names></name>
<name><surname>Macdonald</surname><given-names>B.</given-names></name>
<name><surname>Giattino</surname><given-names>C.</given-names></name>
<name><surname>Appel</surname><given-names>C.</given-names></name>
<name><surname>Rod&#x000e9;s-Guirao</surname><given-names>L.</given-names></name>
<name><surname>Roser</surname><given-names>M.</given-names></name>
</person-group><article-title>Our World in Data. Coronavirus (COVID-19) Vaccinations</article-title><comment>Available online: <ext-link xlink:href="https://ourworldindata.org/covid-vaccinations" ext-link-type="uri">https://ourworldindata.org/covid-vaccinations</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-08-12">(accessed on 12 August 2024)</date-in-citation></element-citation></ref><ref id="B4-vaccines-12-01352"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Steele</surname><given-names>M.K.</given-names></name>
<name><surname>Couture</surname><given-names>A.</given-names></name>
<name><surname>Reed</surname><given-names>C.</given-names></name>
<name><surname>Iuliano</surname><given-names>D.</given-names></name>
<name><surname>Whitaker</surname><given-names>M.</given-names></name>
<name><surname>Fast</surname><given-names>H.</given-names></name>
<name><surname>Hall</surname><given-names>A.J.</given-names></name>
<name><surname>Macneil</surname><given-names>A.</given-names></name>
<name><surname>Cadwell</surname><given-names>B.</given-names></name>
<name><surname>Marks</surname><given-names>K.J.</given-names></name>
<etal/>
</person-group><article-title>Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented among Vaccinated Persons in the US, December 2020 to September 2021</article-title><source>JAMA Netw. Open</source><year>2022</year><volume>5</volume><fpage>e2220385</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2022.20385</pub-id><pub-id pub-id-type="pmid">35793085</pub-id>
</element-citation></ref><ref id="B5-vaccines-12-01352"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Matthew</surname><given-names>P.</given-names></name>
<name><surname>Joanne</surname><given-names>M.</given-names></name>
<name><surname>Patrick</surname><given-names>B.</given-names></name>
<name><surname>Isabelle</surname><given-names>B.</given-names></name>
<name><surname>Tammy</surname><given-names>H.</given-names></name>
<name><surname>Cynthia</surname><given-names>M.</given-names></name>
<name><surname>Larissa</surname><given-names>S.</given-names></name>
<name><surname>Roger</surname><given-names>C.</given-names></name>
<name><surname>Julie</surname><given-names>G.</given-names></name>
<name><surname>Jeremy</surname><given-names>G.</given-names></name>
<etal/>
</person-group><article-title>The PRISMA 2020 statement: An updated guideline for reporting systematic reviews</article-title><source>J. Clin. Epidemiol.</source><year>2021</year><volume>134</volume><fpage>178</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2021.03.001</pub-id><pub-id pub-id-type="pmid">33789819</pub-id>
</element-citation></ref><ref id="B6-vaccines-12-01352"><label>6.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Tufanaru</surname><given-names>C.</given-names></name>
<name><surname>Munn</surname><given-names>Z.</given-names></name>
<name><surname>Aromataris</surname><given-names>E.</given-names></name>
<name><surname>Campbell</surname><given-names>J.</given-names></name>
<name><surname>Hopp</surname><given-names>L.</given-names></name>
</person-group><article-title>Chapter 7: Systematic Reviews of Etiology and Risk</article-title><source>JBI Manual for Evidence Synthesis</source><publisher-name>JBI Global</publisher-name><publisher-loc>Adelaide, SA, Australia</publisher-loc><year>2020</year></element-citation></ref><ref id="B7-vaccines-12-01352"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zein</surname><given-names>S.</given-names></name>
<name><surname>Abdallah</surname><given-names>S.B.</given-names></name>
<name><surname>Al-Smadi</surname><given-names>A.</given-names></name>
<name><surname>Gammoh</surname><given-names>O.</given-names></name>
<name><surname>Al-Awaida</surname><given-names>W.J.</given-names></name>
<name><surname>Al-Zein</surname><given-names>H.J.</given-names></name>
</person-group><article-title>Factors Associated with the Unwillingness of Jordanians, Palestinians and Syrians to Be Vaccinated against COVID-19</article-title><source>PLoS Negl. Trop. Dis.</source><year>2021</year><volume>15</volume><elocation-id>e0009957</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0009957</pub-id><pub-id pub-id-type="pmid">34882673</pub-id>
</element-citation></ref><ref id="B8-vaccines-12-01352"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Neely</surname><given-names>S.R.</given-names></name>
<name><surname>Eldredge</surname><given-names>C.</given-names></name>
<name><surname>Ersing</surname><given-names>R.</given-names></name>
<name><surname>Remington</surname><given-names>C.</given-names></name>
</person-group><article-title>Vaccine Hesitancy and Exposure to Misinformation: A Survey Analysis</article-title><source>J. Gen. Intern. Med.</source><year>2022</year><volume>37</volume><fpage>179</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1007/s11606-021-07171-z</pub-id><pub-id pub-id-type="pmid">34671900</pub-id>
</element-citation></ref><ref id="B9-vaccines-12-01352"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gerretsen</surname><given-names>P.</given-names></name>
<name><surname>Kim</surname><given-names>J.</given-names></name>
<name><surname>Caravaggio</surname><given-names>F.</given-names></name>
<name><surname>Quilty</surname><given-names>L.</given-names></name>
<name><surname>Sanches</surname><given-names>M.</given-names></name>
<name><surname>Wells</surname><given-names>S.</given-names></name>
<name><surname>Brown</surname><given-names>E.E.</given-names></name>
<name><surname>Agic</surname><given-names>B.</given-names></name>
<name><surname>Pollock</surname><given-names>B.G.</given-names></name>
<name><surname>Graff-Guerrero</surname><given-names>A.</given-names></name>
</person-group><article-title>Individual Determinants of COVID-19 Vaccine Hesitancy</article-title><source>PLoS ONE</source><year>2021</year><volume>16</volume><elocation-id>e0258462</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0258462</pub-id><pub-id pub-id-type="pmid">34788308</pub-id>
</element-citation></ref><ref id="B10-vaccines-12-01352"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kajikawa</surname><given-names>N.</given-names></name>
<name><surname>Yokoya</surname><given-names>S.</given-names></name>
<name><surname>Maeno</surname><given-names>T.</given-names></name>
</person-group><article-title>COVID-19 Vaccination Willingness and Associated Factors in Japanese Primary Care Patients: A Cross-Sectional Study</article-title><source>J. Prim. Care Community Health</source><year>2022</year><volume>13</volume><fpage>21501319221097282</fpage><pub-id pub-id-type="doi">10.1177/21501319221097282</pub-id><pub-id pub-id-type="pmid">35638712</pub-id>
</element-citation></ref><ref id="B11-vaccines-12-01352"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zarbo</surname><given-names>C.</given-names></name>
<name><surname>Candini</surname><given-names>V.</given-names></name>
<name><surname>Ferrari</surname><given-names>C.</given-names></name>
<name><surname>d&#x02019;Addazio</surname><given-names>M.</given-names></name>
<name><surname>Calamandrei</surname><given-names>G.</given-names></name>
<name><surname>Starace</surname><given-names>F.</given-names></name>
<name><surname>Caserotti</surname><given-names>M.</given-names></name>
<name><surname>Gavaruzzi</surname><given-names>T.</given-names></name>
<name><surname>Lotto</surname><given-names>L.</given-names></name>
<name><surname>Tasso</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>COVID-19 Vaccine Hesitancy in Italy: Predictors of Acceptance, Fence Sitting and Refusal of the COVID-19 Vaccination</article-title><source>Front. Public Health</source><year>2022</year><volume>10</volume><elocation-id>873098</elocation-id><pub-id pub-id-type="doi">10.3389/fpubh.2022.873098</pub-id><pub-id pub-id-type="pmid">35570888</pub-id>
</element-citation></ref><ref id="B12-vaccines-12-01352"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Okubo</surname><given-names>R.</given-names></name>
<name><surname>Yoshioka</surname><given-names>T.</given-names></name>
<name><surname>Ohfuji</surname><given-names>S.</given-names></name>
<name><surname>Matsuo</surname><given-names>T.</given-names></name>
<name><surname>Tabuchi</surname><given-names>T.</given-names></name>
</person-group><article-title>COVID-19 Vaccine Hesitancy and Its Associated Factors in Japan</article-title><source>Vaccines</source><year>2021</year><volume>9</volume><elocation-id>662</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines9060662</pub-id><pub-id pub-id-type="pmid">34204465</pub-id>
</element-citation></ref><ref id="B13-vaccines-12-01352"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tobin</surname><given-names>E.A.</given-names></name>
<name><surname>Okonofua</surname><given-names>M.</given-names></name>
<name><surname>Azeke</surname><given-names>A.</given-names></name>
</person-group><article-title>Acceptance of a COVID-19 Vaccine in Nigeria: A Population-Based Cross-Sectional Study</article-title><source>Ann. Med. Health Sci. Res.</source><year>2021</year><volume>11</volume><fpage>1445</fpage><lpage>1452</lpage></element-citation></ref><ref id="B14-vaccines-12-01352"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lin</surname><given-names>X.Q.</given-names></name>
<name><surname>Zhang</surname><given-names>M.X.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Xue</surname><given-names>J.J.</given-names></name>
<name><surname>Chen</surname><given-names>H.D.</given-names></name>
<name><surname>Tung</surname><given-names>T.H.</given-names></name>
<name><surname>Zhu</surname><given-names>J.S.</given-names></name>
</person-group><article-title>Relationship between Knowledge, Attitudes, and Practices and COVID-19 Vaccine Hesitancy: A Cross-Sectional Study in Taizhou, China</article-title><source>Front. Med.</source><year>2022</year><volume>9</volume><elocation-id>770933</elocation-id><pub-id pub-id-type="doi">10.3389/fmed.2022.770933</pub-id><pub-id pub-id-type="pmid">36082277</pub-id>
</element-citation></ref><ref id="B15-vaccines-12-01352"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shawki</surname><given-names>M.A.</given-names></name>
<name><surname>Kamel</surname><given-names>A.</given-names></name>
<name><surname>Gamal</surname><given-names>S.</given-names></name>
<name><surname>Abbassi</surname><given-names>M.M.</given-names></name>
<name><surname>Farid</surname><given-names>S.F.</given-names></name>
<name><surname>Sabry</surname><given-names>N.A.</given-names></name>
</person-group><article-title>COVID-19 Vaccine Hesitancy in Egypt: A Cross-Sectional Study</article-title><source>J. Infect. Dev. Ctries.</source><year>2023</year><volume>17</volume><fpage>1188</fpage><lpage>1198</lpage><pub-id pub-id-type="doi">10.3855/jidc.17794</pub-id><pub-id pub-id-type="pmid">37824346</pub-id>
</element-citation></ref><ref id="B16-vaccines-12-01352"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Borga</surname><given-names>L.G.</given-names></name>
<name><surname>Clark</surname><given-names>A.E.</given-names></name>
<name><surname>D&#x02019;Ambrosio</surname><given-names>C.</given-names></name>
<name><surname>Lepinteur</surname><given-names>A.</given-names></name>
</person-group><article-title>Characteristics Associated with COVID-19 Vaccine Hesitancy</article-title><source>Sci. Rep.</source><year>2022</year><volume>12</volume><elocation-id>12435</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-022-16572-x</pub-id><pub-id pub-id-type="pmid">35859048</pub-id>
</element-citation></ref><ref id="B17-vaccines-12-01352"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ogunbosi</surname><given-names>B.O.</given-names></name>
<name><surname>Alao</surname><given-names>M.A.</given-names></name>
<name><surname>Ibrahim</surname><given-names>O.R.</given-names></name>
<name><surname>Ayuk</surname><given-names>A.C.</given-names></name>
<name><surname>Ibraheem</surname><given-names>R.M.</given-names></name>
<name><surname>Odimegwu</surname><given-names>C.L.</given-names></name>
<name><surname>Ikwuka</surname><given-names>D.C.</given-names></name>
<name><surname>Akintan</surname><given-names>P.</given-names></name>
<name><surname>Morakinyo</surname><given-names>O.</given-names></name>
<name><surname>Adeyemi</surname><given-names>A.T.</given-names></name>
<etal/>
</person-group><article-title>COVID-19 Vaccine Hesitancy in Six Geopolitical Zones in Nigeria: A Cross-Sectional Survey</article-title><source>Pan Afr. Med. J.</source><year>2022</year><volume>42</volume><fpage>179</fpage><pub-id pub-id-type="doi">10.11604/pamj.2022.42.179.34135</pub-id><pub-id pub-id-type="pmid">36187029</pub-id>
</element-citation></ref><ref id="B18-vaccines-12-01352"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Boon-itt</surname><given-names>S.</given-names></name>
<name><surname>Rompho</surname><given-names>N.</given-names></name>
<name><surname>Jiarnkamolchurn</surname><given-names>S.</given-names></name>
<name><surname>Skunkan</surname><given-names>Y.</given-names></name>
</person-group><article-title>Interaction between Age and Health Conditions in the Intention to Be Vaccinated against COVID-19 in Thailand</article-title><source>Hum. Vaccines Immunother.</source><year>2021</year><volume>17</volume><fpage>4816</fpage><lpage>4822</lpage><pub-id pub-id-type="doi">10.1080/21645515.2021.1979378</pub-id><pub-id pub-id-type="pmid">34613887</pub-id>
</element-citation></ref><ref id="B19-vaccines-12-01352"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moeed</surname><given-names>A.</given-names></name>
<name><surname>Najeeb</surname><given-names>H.</given-names></name>
<name><surname>Saleem</surname><given-names>A.</given-names></name>
<name><surname>Asghar</surname><given-names>M.S.</given-names></name>
<name><surname>Rafi</surname><given-names>H.M.</given-names></name>
<name><surname>Khattak</surname><given-names>A.K.</given-names></name>
<name><surname>Bilal</surname><given-names>Z.</given-names></name>
<name><surname>Seboka</surname><given-names>B.T.</given-names></name>
</person-group><article-title>Willingness and Perceptions Regarding COVID-19 Vaccine Booster Dose in Pakistani Vaccinated Population: A Cross-Sectional Survey</article-title><source>Front. Public Health</source><year>2022</year><volume>10</volume><elocation-id>911518</elocation-id><pub-id pub-id-type="doi">10.3389/fpubh.2022.911518</pub-id><pub-id pub-id-type="pmid">35844859</pub-id>
</element-citation></ref><ref id="B20-vaccines-12-01352"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yahia</surname><given-names>A.I.O.</given-names></name>
<name><surname>Alshahrani</surname><given-names>A.M.</given-names></name>
<name><surname>Alsulmi</surname><given-names>W.G.H.</given-names></name>
<name><surname>Alqarni</surname><given-names>M.M.M.</given-names></name>
<name><surname>Abdulrahim</surname><given-names>T.K.A.</given-names></name>
<name><surname>Heba</surname><given-names>W.F.H.</given-names></name>
<name><surname>Alqarni</surname><given-names>T.A.A.</given-names></name>
<name><surname>Alharthi</surname><given-names>K.A.Z.</given-names></name>
<name><surname>Buhran</surname><given-names>A.A.A.</given-names></name>
</person-group><article-title>Determinants of COVID-19 Vaccine Acceptance and Hesitancy: A Cross-Sectional Study in Saudi Arabia</article-title><source>Hum. Vaccines Immunother.</source><year>2021</year><volume>17</volume><fpage>4015</fpage><lpage>4020</lpage><pub-id pub-id-type="doi">10.1080/21645515.2021.1950506</pub-id></element-citation></ref><ref id="B21-vaccines-12-01352"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Umakanthan</surname><given-names>S.</given-names></name>
<name><surname>Bukelo</surname><given-names>M.M.</given-names></name>
<name><surname>Bukelo</surname><given-names>M.J.</given-names></name>
<name><surname>Patil</surname><given-names>S.</given-names></name>
<name><surname>Subramaniam</surname><given-names>N.</given-names></name>
<name><surname>Sharma</surname><given-names>R.</given-names></name>
</person-group><article-title>Social Environmental Predictors of COVID-19 Vaccine Hesitancy in India: A Population-Based Survey</article-title><source>Vaccines</source><year>2022</year><volume>10</volume><elocation-id>1749</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines10101749</pub-id><pub-id pub-id-type="pmid">36298614</pub-id>
</element-citation></ref><ref id="B22-vaccines-12-01352"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Okmi</surname><given-names>E.A.</given-names></name>
<name><surname>Almohammadi</surname><given-names>E.</given-names></name>
<name><surname>Alaamri</surname><given-names>O.</given-names></name>
<name><surname>Alfawaz</surname><given-names>R.</given-names></name>
<name><surname>Alomari</surname><given-names>N.</given-names></name>
<name><surname>Saleh</surname><given-names>M.</given-names></name>
<name><surname>Alsuwailem</surname><given-names>S.</given-names></name>
<name><surname>Moafa</surname><given-names>N.J.</given-names></name>
</person-group><article-title>Determinants of COVID-19 Vaccine Acceptance Among the General Adult Population in Saudi Arabia Based on the Health Belief Model: A Web-Based Cross-Sectional Study</article-title><source>Cureus</source><year>2022</year><volume>14</volume><fpage>e28326</fpage><pub-id pub-id-type="doi">10.7759/cureus.28326</pub-id><pub-id pub-id-type="pmid">36168376</pub-id>
</element-citation></ref><ref id="B23-vaccines-12-01352"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Afreh</surname><given-names>O.K.</given-names></name>
<name><surname>Angwaawie</surname><given-names>P.</given-names></name>
<name><surname>Attivor</surname><given-names>E.J.K.</given-names></name>
<name><surname>Boateng</surname><given-names>L.A.</given-names></name>
<name><surname>Brackstone</surname><given-names>K.</given-names></name>
<name><surname>Head</surname><given-names>M.G.</given-names></name>
<name><surname>Manyeh</surname><given-names>A.K.</given-names></name>
<name><surname>Vidzro</surname><given-names>G.A.A.</given-names></name>
</person-group><article-title>Examining Confidence and Hesitancy towards COVID-19 Vaccines: A Cross-Sectional Survey Using in-Person Data Collection in Rural Ghana</article-title><source>Vaccine</source><year>2023</year><volume>41</volume><fpage>2113</fpage><lpage>2119</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2023.02.024</pub-id><pub-id pub-id-type="pmid">36822965</pub-id>
</element-citation></ref><ref id="B24-vaccines-12-01352"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brackstone</surname><given-names>K.</given-names></name>
<name><surname>Atengble</surname><given-names>K.</given-names></name>
<name><surname>Head</surname><given-names>M.</given-names></name>
<name><surname>Boateng</surname><given-names>L.</given-names></name>
</person-group><article-title>COVID-19 Vaccine Hesitancy Trends in Ghana: A Cross-Sectional Study Exploring the Roles of Political Allegiance, Misinformation Beliefs, and Sociodemographic Factors</article-title><source>Pan Afr. Med. J.</source><year>2022</year><volume>43</volume><fpage>165</fpage><pub-id pub-id-type="doi">10.11604/pamj.2022.43.165.37314</pub-id><pub-id pub-id-type="pmid">36825126</pub-id>
</element-citation></ref><ref id="B25-vaccines-12-01352"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Osuagwu</surname><given-names>U.L.</given-names></name>
<name><surname>Mashige</surname><given-names>K.P.</given-names></name>
<name><surname>Ovenseri-Ogbomo</surname><given-names>G.</given-names></name>
<name><surname>Envuladu</surname><given-names>E.A.</given-names></name>
<name><surname>Abu</surname><given-names>E.K.</given-names></name>
<name><surname>Miner</surname><given-names>C.A.</given-names></name>
<name><surname>Timothy</surname><given-names>C.G.</given-names></name>
<name><surname>Ekpenyong</surname><given-names>B.N.</given-names></name>
<name><surname>Langsi</surname><given-names>R.</given-names></name>
<name><surname>Amiebenomo</surname><given-names>O.M.</given-names></name>
<etal/>
</person-group><article-title>The Impact of Information Sources on COVID-19 Vaccine Hesitancy and Resistance in Sub-Saharan Africa</article-title><source>BMC Public Health</source><year>2023</year><volume>23</volume><elocation-id>38</elocation-id><pub-id pub-id-type="doi">10.1186/s12889-022-14972-2</pub-id><pub-id pub-id-type="pmid">36609264</pub-id>
</element-citation></ref><ref id="B26-vaccines-12-01352"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alzahrani</surname><given-names>S.H.</given-names></name>
<name><surname>Baig</surname><given-names>M.</given-names></name>
<name><surname>Alrabia</surname><given-names>M.W.</given-names></name>
<name><surname>Algethami</surname><given-names>M.R.</given-names></name>
<name><surname>Alhamdan</surname><given-names>M.M.</given-names></name>
<name><surname>Alhakamy</surname><given-names>N.A.</given-names></name>
<name><surname>Asfour</surname><given-names>H.Z.</given-names></name>
<name><surname>Ahmad</surname><given-names>T.</given-names></name>
</person-group><article-title>Attitudes toward the SARS-CoV-2 Vaccine: Results from the Saudi Residents&#x02019; Intention to Get Vaccinated against COVID-19 (Srigvac) Study</article-title><source>Vaccines</source><year>2021</year><volume>9</volume><elocation-id>798</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines9070798</pub-id><pub-id pub-id-type="pmid">34358214</pub-id>
</element-citation></ref><ref id="B27-vaccines-12-01352"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tram</surname><given-names>K.H.</given-names></name>
<name><surname>Saeed</surname><given-names>S.</given-names></name>
<name><surname>Bradley</surname><given-names>C.</given-names></name>
<name><surname>Fox</surname><given-names>B.</given-names></name>
<name><surname>Eshun-Wilson</surname><given-names>I.</given-names></name>
<name><surname>Mody</surname><given-names>A.</given-names></name>
<name><surname>Geng</surname><given-names>E.</given-names></name>
</person-group><article-title>Deliberation, Dissent, and Distrust: Understanding Distinct Drivers of Coronavirus Disease 2019 Vaccine Hesitancy in the United States</article-title><source>Clin. Infect. Dis.</source><year>2022</year><volume>74</volume><fpage>1429</fpage><lpage>1441</lpage><pub-id pub-id-type="doi">10.1093/cid/ciab633</pub-id><pub-id pub-id-type="pmid">34272559</pub-id>
</element-citation></ref><ref id="B28-vaccines-12-01352"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abouhala</surname><given-names>S.</given-names></name>
<name><surname>Hamidaddin</surname><given-names>A.</given-names></name>
<name><surname>Taye</surname><given-names>M.</given-names></name>
<name><surname>Glass</surname><given-names>D.J.</given-names></name>
<name><surname>Zanial</surname><given-names>N.</given-names></name>
<name><surname>Hammood</surname><given-names>F.</given-names></name>
<name><surname>Allouch</surname><given-names>F.</given-names></name>
<name><surname>Abuelezam</surname><given-names>N.N.</given-names></name>
</person-group><article-title>A National Survey Assessing COVID-19 Vaccine Hesitancy Among Arab Americans</article-title><source>J. Racial Ethn. Health Disparities</source><year>2022</year><volume>9</volume><fpage>2188</fpage><lpage>2196</lpage><pub-id pub-id-type="doi">10.1007/s40615-021-01158-6</pub-id><pub-id pub-id-type="pmid">34625919</pub-id>
</element-citation></ref><ref id="B29-vaccines-12-01352"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Steinmetz</surname><given-names>L.</given-names></name>
</person-group><article-title>Sociodemographic Predictors of and Main Reasons for COVID-19 Vaccine Hesitancy in Eastern Oslo: A Cross-Sectional Study</article-title><source>BMC Public Health</source><year>2022</year><volume>22</volume><elocation-id>1878</elocation-id><pub-id pub-id-type="doi">10.1186/s12889-022-14261-y</pub-id><pub-id pub-id-type="pmid">36207702</pub-id>
</element-citation></ref><ref id="B30-vaccines-12-01352"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brailovskaia</surname><given-names>J.</given-names></name>
<name><surname>Schneider</surname><given-names>S.</given-names></name>
<name><surname>Margraf</surname><given-names>J.</given-names></name>
</person-group><article-title>To Vaccinate or Not to Vaccinate!? Predictors of Willingness to Receive COVID-19 Vaccination in Europe, the U.S., and China</article-title><source>PLoS ONE</source><year>2021</year><volume>16</volume><elocation-id>e0260230</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0260230</pub-id><pub-id pub-id-type="pmid">34851986</pub-id>
</element-citation></ref><ref id="B31-vaccines-12-01352"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yohannes</surname><given-names>S.</given-names></name>
<name><surname>Alemayehu</surname><given-names>A.</given-names></name>
<name><surname>Woldesenbet</surname><given-names>Y.M.</given-names></name>
<name><surname>Tadele</surname><given-names>T.</given-names></name>
<name><surname>Dangiso</surname><given-names>D.</given-names></name>
<name><surname>Birhanu</surname><given-names>M.</given-names></name>
<name><surname>Woldesemayat</surname><given-names>E.M.</given-names></name>
</person-group><article-title>COVID-19 Vaccine Hesitancy among Adults in Hawassa City Administration, Sidama Region, Ethiopia: A Community-Based Study</article-title><source>Front. Public Health</source><year>2023</year><volume>11</volume><elocation-id>1122418</elocation-id><pub-id pub-id-type="doi">10.3389/fpubh.2023.1122418</pub-id><pub-id pub-id-type="pmid">36935692</pub-id>
</element-citation></ref><ref id="B32-vaccines-12-01352"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dinesh</surname><given-names>R.J.</given-names></name>
<name><surname>Dhanalakshmi</surname><given-names>R.</given-names></name>
<name><surname>Jency</surname><given-names>P.J.</given-names></name>
<name><surname>Srividya</surname><given-names>A.</given-names></name>
<name><surname>Vijayakumar</surname><given-names>B.</given-names></name>
<name><surname>Kumar</surname><given-names>A.</given-names></name>
</person-group><article-title>Factors for Hesitancy towards Vaccination against COVID-19 among the Adult Population in Puducherry, India&#x02014;A Cross Sectional Study</article-title><source>BMC Public Health</source><year>2023</year><volume>23</volume><elocation-id>2217</elocation-id><pub-id pub-id-type="doi">10.1186/s12889-023-17095-4</pub-id><pub-id pub-id-type="pmid">37950181</pub-id>
</element-citation></ref><ref id="B33-vaccines-12-01352"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Savoia</surname><given-names>E.</given-names></name>
<name><surname>Piltch-Loeb</surname><given-names>R.</given-names></name>
<name><surname>Goldberg</surname><given-names>B.</given-names></name>
<name><surname>Miller-Idriss</surname><given-names>C.</given-names></name>
<name><surname>Hughes</surname><given-names>B.</given-names></name>
<name><surname>Montrond</surname><given-names>A.</given-names></name>
<name><surname>Kayyem</surname><given-names>J.</given-names></name>
<name><surname>Testa</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Predictors of COVID-19 Vaccine Hesitancy: Socio-Demographics, Co-Morbidity, and Past Experience of Racial Discrimination</article-title><source>Vaccines</source><year>2021</year><volume>9</volume><elocation-id>767</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines9070767</pub-id><pub-id pub-id-type="pmid">34358184</pub-id>
</element-citation></ref><ref id="B34-vaccines-12-01352"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ditekemena</surname><given-names>J.D.</given-names></name>
<name><surname>Nkamba</surname><given-names>D.M.</given-names></name>
<name><surname>Mutwadi</surname><given-names>A.</given-names></name>
<name><surname>Mavoko</surname><given-names>H.M.</given-names></name>
<name><surname>Fodjo</surname><given-names>J.N.S.</given-names></name>
<name><surname>Luhata</surname><given-names>C.</given-names></name>
<name><surname>Obimpeh</surname><given-names>M.</given-names></name>
<name><surname>Van Hees</surname><given-names>S.</given-names></name>
<name><surname>Nachega</surname><given-names>J.B.</given-names></name>
<name><surname>Colebunders</surname><given-names>R.</given-names></name>
</person-group><article-title>COVID-19 Vaccine Acceptance in the Democratic Republic of Congo: A Cross-Sectional Survey</article-title><source>Vaccines</source><year>2021</year><volume>9</volume><elocation-id>153</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines9020153</pub-id><pub-id pub-id-type="pmid">33672938</pub-id>
</element-citation></ref><ref id="B35-vaccines-12-01352"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Almalki</surname><given-names>M.</given-names></name>
<name><surname>Sultan</surname><given-names>M.K.</given-names></name>
<name><surname>Abbas</surname><given-names>M.</given-names></name>
<name><surname>Alhazmi</surname><given-names>A.</given-names></name>
<name><surname>Hassan</surname><given-names>Y.</given-names></name>
<name><surname>Varghese</surname><given-names>J.</given-names></name>
</person-group><article-title>COVID-19 Vaccine Hesitancy among Population in Jazan Region of Saudi Arabia</article-title><source>Healthcare</source><year>2023</year><volume>11</volume><elocation-id>3051</elocation-id><pub-id pub-id-type="doi">10.3390/healthcare11233051</pub-id><pub-id pub-id-type="pmid">38063619</pub-id>
</element-citation></ref><ref id="B36-vaccines-12-01352"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Al-Wutayd</surname><given-names>O.</given-names></name>
<name><surname>Khalil</surname><given-names>R.</given-names></name>
<name><surname>Rajar</surname><given-names>A.B.</given-names></name>
</person-group><article-title>Sociodemographic and Behavioral Predictors of COVID-19 Vaccine Hesitancy in Pakistan</article-title><source>J. Multidiscip. Healthc.</source><year>2021</year><volume>14</volume><fpage>2847</fpage><lpage>2856</lpage><pub-id pub-id-type="doi">10.2147/JMDH.S325529</pub-id><pub-id pub-id-type="pmid">34675532</pub-id>
</element-citation></ref><ref id="B37-vaccines-12-01352"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lupu</surname><given-names>D.</given-names></name>
<name><surname>Tiganasu</surname><given-names>R.</given-names></name>
</person-group><article-title>Does Education Influence COVID-19 Vaccination? A Global View</article-title><source>Heliyon</source><year>2024</year><volume>10</volume><fpage>e24709</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2024.e24709</pub-id><pub-id pub-id-type="pmid">38314273</pub-id>
</element-citation></ref><ref id="B38-vaccines-12-01352"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hartley</surname><given-names>K.</given-names></name>
<name><surname>Vu</surname><given-names>M.K.</given-names></name>
</person-group><article-title>Fighting Fake News in the COVID-19 Era: Policy Insights from an Equilibrium Model</article-title><source>Policy Sci.</source><year>2020</year><volume>53</volume><fpage>735</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1007/s11077-020-09405-z</pub-id><pub-id pub-id-type="pmid">32921821</pub-id>
</element-citation></ref><ref id="B39-vaccines-12-01352"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pennycook</surname><given-names>G.</given-names></name>
<name><surname>McPhetres</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Lu</surname><given-names>J.G.</given-names></name>
<name><surname>Rand</surname><given-names>D.G.</given-names></name>
</person-group><article-title>Fighting COVID-19 Misinformation on Social Media: Experimental Evidence for a Scalable Accuracy-Nudge Intervention</article-title><source>Psychol. Sci.</source><year>2020</year><volume>31</volume><fpage>770</fpage><lpage>780</lpage><pub-id pub-id-type="doi">10.1177/0956797620939054</pub-id><pub-id pub-id-type="pmid">32603243</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="vaccines-12-01352-f001"><label>Figure 1</label><caption><p>Flow diagram of articles selection stages.</p></caption><graphic xlink:href="vaccines-12-01352-g001" position="float"/></fig><table-wrap position="float" id="vaccines-12-01352-t001"><object-id pub-id-type="pii">vaccines-12-01352-t001_Table 1</object-id><label>Table 1</label><caption><p>Factors associated with vaccination adherence against COVID-19.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Category</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Associated Factors</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sociodemographic factors</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Age between 18 and 35 [<xref rid="B7-vaccines-12-01352" ref-type="bibr">7</xref>,<xref rid="B8-vaccines-12-01352" ref-type="bibr">8</xref>]</p></list-item><list-item><label>-</label><p>High school or less [<xref rid="B7-vaccines-12-01352" ref-type="bibr">7</xref>,<xref rid="B8-vaccines-12-01352" ref-type="bibr">8</xref>,<xref rid="B9-vaccines-12-01352" ref-type="bibr">9</xref>]</p></list-item><list-item><label>-</label><p>Being male [<xref rid="B7-vaccines-12-01352" ref-type="bibr">7</xref>,<xref rid="B8-vaccines-12-01352" ref-type="bibr">8</xref>,<xref rid="B9-vaccines-12-01352" ref-type="bibr">9</xref>,<xref rid="B10-vaccines-12-01352" ref-type="bibr">10</xref>,<xref rid="B11-vaccines-12-01352" ref-type="bibr">11</xref>,<xref rid="B12-vaccines-12-01352" ref-type="bibr">12</xref>]</p></list-item><list-item><label>-</label><p>Older people, being elderly [<xref rid="B9-vaccines-12-01352" ref-type="bibr">9</xref>,<xref rid="B10-vaccines-12-01352" ref-type="bibr">10</xref>,<xref rid="B11-vaccines-12-01352" ref-type="bibr">11</xref>,<xref rid="B13-vaccines-12-01352" ref-type="bibr">13</xref>,<xref rid="B14-vaccines-12-01352" ref-type="bibr">14</xref>]</p></list-item><list-item><label>-</label><p>Being self-employed [<xref rid="B13-vaccines-12-01352" ref-type="bibr">13</xref>]</p></list-item><list-item><label>-</label><p>White skin color [<xref rid="B10-vaccines-12-01352" ref-type="bibr">10</xref>]</p></list-item></list>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Beliefs experiences during the pandemic</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Protection for themselves and others [<xref rid="B15-vaccines-12-01352" ref-type="bibr">15</xref>]</p></list-item><list-item><label>-</label><p>Fear of illness [<xref rid="B16-vaccines-12-01352" ref-type="bibr">16</xref>,<xref rid="B17-vaccines-12-01352" ref-type="bibr">17</xref>]</p></list-item><list-item><label>-</label><p>Co-morbidities [<xref rid="B8-vaccines-12-01352" ref-type="bibr">8</xref>,<xref rid="B9-vaccines-12-01352" ref-type="bibr">9</xref>,<xref rid="B18-vaccines-12-01352" ref-type="bibr">18</xref>,<xref rid="B19-vaccines-12-01352" ref-type="bibr">19</xref>]</p></list-item></list>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sources of information </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Knowledge [<xref rid="B11-vaccines-12-01352" ref-type="bibr">11</xref>,<xref rid="B20-vaccines-12-01352" ref-type="bibr">20</xref>,<xref rid="B21-vaccines-12-01352" ref-type="bibr">21</xref>,<xref rid="B22-vaccines-12-01352" ref-type="bibr">22</xref>]</p></list-item></list>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Behavioral factors</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Anxiety [<xref rid="B16-vaccines-12-01352" ref-type="bibr">16</xref>]</p></list-item><list-item><label>-</label><p>Right-wing party [<xref rid="B10-vaccines-12-01352" ref-type="bibr">10</xref>]</p></list-item><list-item><label>-</label><p>Previous flu vaccination [<xref rid="B11-vaccines-12-01352" ref-type="bibr">11</xref>]</p></list-item><list-item><label>-</label><p>Perceived risk [<xref rid="B12-vaccines-12-01352" ref-type="bibr">12</xref>]</p></list-item></list>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immunobiologicals</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Knowledge about vaccines [<xref rid="B9-vaccines-12-01352" ref-type="bibr">9</xref>,<xref rid="B11-vaccines-12-01352" ref-type="bibr">11</xref>,<xref rid="B20-vaccines-12-01352" ref-type="bibr">20</xref>,<xref rid="B21-vaccines-12-01352" ref-type="bibr">21</xref>]</p></list-item><list-item><label>-</label><p>Confidence in vaccines [<xref rid="B9-vaccines-12-01352" ref-type="bibr">9</xref>,<xref rid="B11-vaccines-12-01352" ref-type="bibr">11</xref>,<xref rid="B21-vaccines-12-01352" ref-type="bibr">21</xref>]</p></list-item></list>
</td></tr></tbody></table></table-wrap><table-wrap position="float" id="vaccines-12-01352-t002"><object-id pub-id-type="pii">vaccines-12-01352-t002_Table 2</object-id><label>Table 2</label><caption><p>Factors associated with vaccine hesitancy against COVID-19, Ribeir&#x000e3;o Preto, 2024.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Category</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Associated Facctors</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sociodemographic factors</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Female [<xref rid="B11-vaccines-12-01352" ref-type="bibr">11</xref>,<xref rid="B12-vaccines-12-01352" ref-type="bibr">12</xref>,<xref rid="B16-vaccines-12-01352" ref-type="bibr">16</xref>,<xref rid="B20-vaccines-12-01352" ref-type="bibr">20</xref>,<xref rid="B23-vaccines-12-01352" ref-type="bibr">23</xref>,<xref rid="B24-vaccines-12-01352" ref-type="bibr">24</xref>,<xref rid="B25-vaccines-12-01352" ref-type="bibr">25</xref>,<xref rid="B26-vaccines-12-01352" ref-type="bibr">26</xref>,<xref rid="B27-vaccines-12-01352" ref-type="bibr">27</xref>,<xref rid="B28-vaccines-12-01352" ref-type="bibr">28</xref>];</p></list-item><list-item><label>-</label><p>Level of education [<xref rid="B11-vaccines-12-01352" ref-type="bibr">11</xref>,<xref rid="B16-vaccines-12-01352" ref-type="bibr">16</xref>,<xref rid="B20-vaccines-12-01352" ref-type="bibr">20</xref>,<xref rid="B24-vaccines-12-01352" ref-type="bibr">24</xref>,<xref rid="B26-vaccines-12-01352" ref-type="bibr">26</xref>,<xref rid="B27-vaccines-12-01352" ref-type="bibr">27</xref>,<xref rid="B29-vaccines-12-01352" ref-type="bibr">29</xref>]</p></list-item><list-item><label>-</label><p>Age between 34&#x02013;49, over 45 [<xref rid="B20-vaccines-12-01352" ref-type="bibr">20</xref>,<xref rid="B29-vaccines-12-01352" ref-type="bibr">29</xref>];</p></list-item><list-item><label>-</label><p>Urban dwellers [<xref rid="B20-vaccines-12-01352" ref-type="bibr">20</xref>,<xref rid="B24-vaccines-12-01352" ref-type="bibr">24</xref>]</p></list-item><list-item><label>-</label><p>Young people, people on low incomes and people with lower levels of education [<xref rid="B11-vaccines-12-01352" ref-type="bibr">11</xref>,<xref rid="B12-vaccines-12-01352" ref-type="bibr">12</xref>,<xref rid="B14-vaccines-12-01352" ref-type="bibr">14</xref>,<xref rid="B16-vaccines-12-01352" ref-type="bibr">16</xref>,<xref rid="B27-vaccines-12-01352" ref-type="bibr">27</xref>]</p></list-item><list-item><label>-</label><p>Married [<xref rid="B20-vaccines-12-01352" ref-type="bibr">20</xref>]</p></list-item><list-item><label>-</label><p>Employed [<xref rid="B20-vaccines-12-01352" ref-type="bibr">20</xref>]</p></list-item><list-item><label>-</label><p>Black [<xref rid="B11-vaccines-12-01352" ref-type="bibr">11</xref>,<xref rid="B27-vaccines-12-01352" ref-type="bibr">27</xref>]</p></list-item></list>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Experiences during the pandemic</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Stress [<xref rid="B30-vaccines-12-01352" ref-type="bibr">30</xref>];</p></list-item><list-item><label>-</label><p>The use of social medial [<xref rid="B23-vaccines-12-01352" ref-type="bibr">23</xref>]</p></list-item><list-item><label>-</label><p>Psychological distress [<xref rid="B12-vaccines-12-01352" ref-type="bibr">12</xref>]</p></list-item></list>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sources of information </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>The use of social media and the internet to obtain information [<xref rid="B24-vaccines-12-01352" ref-type="bibr">24</xref>,<xref rid="B30-vaccines-12-01352" ref-type="bibr">30</xref>].</p></list-item><list-item><label>-</label><p>Lack of information [<xref rid="B7-vaccines-12-01352" ref-type="bibr">7</xref>,<xref rid="B23-vaccines-12-01352" ref-type="bibr">23</xref>,<xref rid="B24-vaccines-12-01352" ref-type="bibr">24</xref>,<xref rid="B31-vaccines-12-01352" ref-type="bibr">31</xref>]</p></list-item><list-item><label>-</label><p>Use of television and Facebook [<xref rid="B25-vaccines-12-01352" ref-type="bibr">25</xref>]</p></list-item></list>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immunobiologicals </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Distrust of the vaccine [<xref rid="B9-vaccines-12-01352" ref-type="bibr">9</xref>,<xref rid="B17-vaccines-12-01352" ref-type="bibr">17</xref>,<xref rid="B23-vaccines-12-01352" ref-type="bibr">23</xref>,<xref rid="B24-vaccines-12-01352" ref-type="bibr">24</xref>];</p></list-item><list-item><label>-</label><p>Concern about side effects/adverse events [<xref rid="B8-vaccines-12-01352" ref-type="bibr">8</xref>,<xref rid="B12-vaccines-12-01352" ref-type="bibr">12</xref>,<xref rid="B23-vaccines-12-01352" ref-type="bibr">23</xref>,<xref rid="B31-vaccines-12-01352" ref-type="bibr">31</xref>,<xref rid="B32-vaccines-12-01352" ref-type="bibr">32</xref>];</p></list-item><list-item><label>-</label><p>Confidence in the safety and efficacy of vaccines [<xref rid="B7-vaccines-12-01352" ref-type="bibr">7</xref>,<xref rid="B8-vaccines-12-01352" ref-type="bibr">8</xref>,<xref rid="B9-vaccines-12-01352" ref-type="bibr">9</xref>,<xref rid="B13-vaccines-12-01352" ref-type="bibr">13</xref>,<xref rid="B14-vaccines-12-01352" ref-type="bibr">14</xref>,<xref rid="B20-vaccines-12-01352" ref-type="bibr">20</xref>,<xref rid="B22-vaccines-12-01352" ref-type="bibr">22</xref>,<xref rid="B24-vaccines-12-01352" ref-type="bibr">24</xref>,<xref rid="B33-vaccines-12-01352" ref-type="bibr">33</xref>,<xref rid="B34-vaccines-12-01352" ref-type="bibr">34</xref>,<xref rid="B35-vaccines-12-01352" ref-type="bibr">35</xref>,<xref rid="B36-vaccines-12-01352" ref-type="bibr">36</xref>]</p></list-item><list-item><label>-</label><p>Possible long-term health risks associated with vaccines [<xref rid="B7-vaccines-12-01352" ref-type="bibr">7</xref>,<xref rid="B31-vaccines-12-01352" ref-type="bibr">31</xref>]</p></list-item><list-item><label>-</label><p>Fear of needles [<xref rid="B32-vaccines-12-01352" ref-type="bibr">32</xref>]</p></list-item><list-item><label>-</label><p>Belief in acquired immunity [<xref rid="B32-vaccines-12-01352" ref-type="bibr">32</xref>]</p></list-item></list>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Religion </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Have some religion [<xref rid="B13-vaccines-12-01352" ref-type="bibr">13</xref>,<xref rid="B23-vaccines-12-01352" ref-type="bibr">23</xref>,<xref rid="B24-vaccines-12-01352" ref-type="bibr">24</xref>,<xref rid="B28-vaccines-12-01352" ref-type="bibr">28</xref>,<xref rid="B32-vaccines-12-01352" ref-type="bibr">32</xref>],</p></list-item></list>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Behavioral factors</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Racial discrimination [<xref rid="B33-vaccines-12-01352" ref-type="bibr">33</xref>,<xref rid="B34-vaccines-12-01352" ref-type="bibr">34</xref>];</p></list-item><list-item><label>-</label><p>Use of alcohol and tobacco [<xref rid="B32-vaccines-12-01352" ref-type="bibr">32</xref>];</p></list-item><list-item><label>-</label><p>Not trusting the government [<xref rid="B13-vaccines-12-01352" ref-type="bibr">13</xref>,<xref rid="B16-vaccines-12-01352" ref-type="bibr">16</xref>]</p></list-item><list-item><label>-</label><p>Voters from opposition political parties [<xref rid="B24-vaccines-12-01352" ref-type="bibr">24</xref>,<xref rid="B27-vaccines-12-01352" ref-type="bibr">27</xref>].</p></list-item><list-item><label>-</label><p>Low perception of severity and/or risk. [<xref rid="B9-vaccines-12-01352" ref-type="bibr">9</xref>,<xref rid="B26-vaccines-12-01352" ref-type="bibr">26</xref>,<xref rid="B31-vaccines-12-01352" ref-type="bibr">31</xref>,<xref rid="B34-vaccines-12-01352" ref-type="bibr">34</xref>,<xref rid="B35-vaccines-12-01352" ref-type="bibr">35</xref>,<xref rid="B36-vaccines-12-01352" ref-type="bibr">36</xref>]</p></list-item></list>
</td></tr></tbody></table></table-wrap></floats-group></article>